genomic alterations which serve as the driving force in initiating tumor development and propelling tumor progression. Recent advances in molecular genomic technology and the success of human genome project have empowered investigators with new tools in analyzing cancer genome and transcriptome in great details and have expedited the discovery of new cancer-associated genes. Decoding the genetic history present in tumor DNA, as well as identification and characterization of molecular changes involving cancer-associated genes and the pathways they controlled, has not only shed new light on the molecular etiology of cancer, but also has promises for the development of new diagnostic markers and novel therapeutics. In this special issue, the papers focus on recent findings of markers identified in female reproductive cancers including breast, ovarian, endometrial, and trophoblast tumors. The selected papers are not an exhaustive representation of the area of biomarkers in female reproductive cancers. Nonetheless, they represent the rich and many-faceted knowledge that we have the pleasure of sharing that with readers. We would like to thank the authors for their excellent contributions to this special issue and the reviewers' insightful input to ensure the quality of this special issue.
Of The findings from those studies could serve as biological foundation for future exploration of how those markers contribute to disease progression. The biomarkers identified in these studies could also serve as a road map for development of novel diagnosis tools and new targeted therapies. This issue also reports a synergistic effect of Pten loss and oncogenic Kras mutation on the endometrial cancer development (I. H. Kim et al.) and the result provides new insight into the pathogenesis of endometrial carcinoma. Finally, K. L. Yap et al. applied molecular genetic markers to demonstrate a lack of a Y-chromosomal complement in the majority of gestational trophoblastic neoplasms, suggesting that most trophoblastic tumors are derived from previous molar gestations. Because the molecular characters in gestational trophoblastic disease are understudied, this short report should provide new insight into the pathogenesis of this rare but highly interesting gynecological neoplasm.
In conclusion, this special issue is by no means an attempt to be comprehensive in covering the field of female reproductive cancer, but it provides excellent reviews and research articles that may be useful for readers in this field. We hope that this special issue will inspire investigators in launching new research endeavor in this field and are grateful for the opportunity to manage this special issue.
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